Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/79974
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLevin, M.-
dc.contributor.authorRydnert, F.-
dc.contributor.authorKallstrom, E.-
dc.contributor.authorTan, L.-
dc.contributor.authorWormald, P.-
dc.contributor.authorLindstedt, M.-
dc.contributor.authorGreiff, L.-
dc.contributor.authorOhlin, M.-
dc.date.issued2013-
dc.identifier.citationJournal of Immunology, 2013; 191(2):551-560-
dc.identifier.issn0022-1767-
dc.identifier.issn1550-6606-
dc.identifier.urihttp://hdl.handle.net/2440/79974-
dc.description.abstractDetailed understanding of how Abs of the IgE isotype interact with allergen at the onset of an allergic reaction is of great importance for deciphering mechanisms involved in the development of disease and may aid in the design of hypoallergenic variants. In this study, we have used a set of human monoclonal IgE Abs derived from the repertoires of allergic individuals, specific for the major timothy grass pollen allergen Phl p 1, to gain detailed information on the interaction between Abs and allergen. These allergen-specific IgE are to varying degrees cross-reactive toward both different allergen isoforms and various group 1 allergens originating from other grass species. The usage of human monoclonal IgE, as an alternative to polyclonal preparations or mouse Abs, allowed us to locate several important IgE-binding epitopes on the C-terminal domain of Phl p 1, all clustered to an IgE-binding “hot spot.” By introducing three mutations in the IgE-binding area of the C-terminal domain we were able to significantly reduce its reactivity with serum IgE. In conclusion, our study shows the great potential of using human monoclonal IgE as a tool for studies of the molecular interactions taking place during allergic responses. Furthermore, we present a novel IgE-hyporeactive fragment with the potential to be used as a safer hypoallergenic alternative in specific immunotherapy than the pollen extracts used today.-
dc.description.statementofresponsibilityMattias Levin, Frida Rydnert, Eva Källström, Lor Wai Tan, Peter J. Wormald, Malin Lindstedt, Lennart Greiff, and Mats Ohlin-
dc.language.isoen-
dc.publisherAmer Assoc Immunologists-
dc.rightsCopyright © 2013 by The American Association of Immunologists-
dc.source.urihttp://dx.doi.org/10.4049/jimmunol.1202051-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectMice-
dc.subjectPollen-
dc.subjectHypersensitivity-
dc.subjectImmunoglobulin E-
dc.subjectPlant Proteins-
dc.subjectPlant Extracts-
dc.subjectAntibodies, Monoclonal-
dc.subjectBinding Sites, Antibody-
dc.subjectAllergens-
dc.subjectEpitopes-
dc.subjectSequence Alignment-
dc.subjectCross Reactions-
dc.subjectAmino Acid Sequence-
dc.subjectMolecular Sequence Data-
dc.subjectRhinitis, Allergic, Seasonal-
dc.subjectAntigens, Plant-
dc.titlePhl p 1-Specific Human Monoclonal IgE and Design of a Hypoallergenic Group 1 Grass Pollen Allergen Fragment-
dc.typeJournal article-
dc.identifier.doi10.4049/jimmunol.1202051-
pubs.publication-statusPublished-
dc.identifier.orcidWormald, P. [0000-0001-7753-7277]-
Appears in Collections:Aurora harvest 4
Surgery publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.